Brainsway Ltd. occupies a unique niche in the field of medical technology with its flagship product - the Deep Transcranial Magnetic Stimulation (Deep TMS) system. This cutting-edge technology offers an innovative approach to treating a wide range of neurological and psychiatric disorders, including major depressive disorder and obsessive-compulsive disorder,...
BWAY: BrainsWay 2022-01-31 07:30:00 BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS™ for the Treatment of OCD
BWAY: BrainsWay 2021-06-01 08:00:00 BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor
About: BrainsWay is dedicated to developing and providing advanced solutions for brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. BrainsWay’s flagship technology, which is based on Deep Transcranial Magnetic Stimulation (TMS), launches a new era in brain disorder...